Ofloxacine (Tarivid-Hoechst) was used in 30 patients with infections of the respiratory system, including 12 with pneumonias, 18 with chronic bronchitis. The agent was given in oral form, in a 200 mg tablet every 12 hours for 7 to 10 days. Therapeutical and tolerance was analyzed being on clinical radiological, biochemical and bacteriological findings. Complete remission was found in 21 patients, in 7 more a significant clinical and radiological improvement was found. Altogether in 93.3% of the treated patients the therapeutical efficacy of the agent was found to be excellent. During treatment side effects were not observed. The results if this study demonstrate a high therapeutical efficacy and safety of the agent.